Fachinformation cisplatin accord

Author: tgse

August undefined, 2024

WebCisplatin is only given by injection into a vein (an intravenous infusion). Supportive equipment should be available to control anaphylactic reactions. Cisplatin should not come into contact with any materials that contain aluminium. The recommended dosage of Cisplatin depends on your well-being, the WebBehandlung mit Cisplatin eine aus-reichende Diurese zu gewährleisten. Für diesen Zweck wird die folgende Lösung intravenös infundiert: Natriumchloridlösung 0,9 % Art der Anwendung Cisplatin Accord 1 mg/ml Konzentrat zur Herstellung einer Infusionslösung muss vor der Anwendung verdünnt werden. Anweisungen zur Verdünnung

Pakkausseloste: Tietoa käyttäjälle Cisplatin Accord 1 …

WebA Patient Information Leaflet (PIL) is a document included in the package of a medication that provides specific information about that medication and its use. It includes information about dose and administration of the medicine, warnings and … WebCisplatina Accord 1 mg / ml x 1 flacon x 10 ml concentrat pentru solutie perfuzbila - Catena. Cisplatina apartine unui grup de medicamente cunoscute sub numele de citostatice, care sunt utilizate în tratamentul cancerului. Cisplatina poate fi utilizată singură, dar si in asociere cu alte citostatice. ... critical appraisal adalah pdf

Cisplatin Accord 1 Mg/Ml Konzentrat Zur Herstellung Einer ...

WebCisplatin for injection is indicated for the treatment of advanced bladder cancer. 2 DOSAGE AND ADMINISTRATION . 2.1 Hydration and Anti-Emetic Treatment . Patients treated with cisplatin for... Webexperienced nephrotoxicity as a result of cisplatin therapy. The carcinogenic potential of carboplatin has not been studied but compounds with similar mechanisms of action and mutagenicity have been reported to be carcinogenic (see section 5.3). Monitoring and neurological examinations should be carried out at regular intervals. Visual ... WebFACHINFORMATION Juni 2024 Seite 1 von 6 Cisplatin Accord 1 mg/ml Konzentrat zur Herstellung einer Infusionslösung FI_76804_V.03 1. BEZEICHNUNG DES ARZNEIMIT-TELS Cisplatin Accord 1 mg/ml Konzentrat zur Herstellung einer Infusionslösung 2. QUALITATIVE UND QUANTITATIVE ZUSAMMENSETZUNG 1 ml des Konzentrats zur … maniscalco sambreville

Injectables Products - Accord Healthcare

WebCisplatin Injection is a clear, colorless to pale yellow, sterile aqueous solution. Each 50 mL or 100 mL amber vial of Cisplatin Injection contains: 1 mg/mL cisplatin, 9 mg/mL sodium chloride, hydrochloric acid and/or sodium hydroxide to adjust pH, and water for injection to a final volume of 50 mL or 100 mL, respectively. WebNov 30, 2024 · Cisplatin reacts with metallic aluminium to form a black precipitate of platinum. All aluminium containing IV sets, needles, catheters and syringes should be avoided. Cisplatin must be administered under close supervision by a qualified doctor specialized in the use of chemotherapeutic agents. maniscalco prudential centerWebCisplatin Accord 1 mg/1 mL is available as a 10 mg/10 mL, 25 mg/25 mL, 50 mg/50 mL and 100 mg/100 mL solution for injection. For the full list of excipients, see . Section 6.1 List of Excipients. 3 PHARMACEUTICAL FORM . Solution for injection . Cisplatin Accord injection is a clear, colourless to pale yellow sterile solution of cisplatin 1 mg ... maniscalco pubblicita casteldaccia

"WebDec 13, 2016 · Cisplatin injection has been administered at 20 mg/m intravenously daily for 5 days per cycle. Other doses and combination regimens have been used. 2.3 Advanced Ovarian Cancer Cisplatin injection has been administered at 75 mg/m to 100 mg/m intravenously per cycle once every 3 to 4 weeks on Day 1. Other doses and combination … " - Fachinformation cisplatin accord

Fachinformation cisplatin accord

Cisplatin 1 mg/ml Concentrate for Regulatory ... - Accord …

WebMay 30, 2024 · We supply branded generics and in-licensed patented products from our local manufacturing facilities to retail and hospital customers across the MENA region Generics. We supply oral and other non‑injectable generic and specialty products to the US retail market, leveraging our state-of-theart manufacturing facility in Columbus, Ohio

Did you know?

WebZu diesem Präparat liegt uns leider keine offizielle Fachinformation der Firma Accord Healthcare GmbH vor. Unter Cisplatin Accord 1 mg/ml Konzentrat zur Herstellung einer Infusionslösung, 10 ml finden Sie alle uns aktuell vorliegenden Informationen zum Präparat. WebFACHINFORMATION Cisplatin Teva®1 mg / ml Konzentrat zur Herstellung einer Infusionslösung. 4 rund 21 Tagen ist ein Abfallen der Throm- bozytenzahl zu verzeichnen (weniger als 10 % der Patienten zeigen eine Gesamtzahl von unter 50 × 109/l) (die Erholungsphase dauert etwa 39 Tage).

WebCisplatin USP, the active ingredient in Cisplatin Injection, is an orange-yellow crystalline powder with the molecular formula Cl 2 H 6 N 2 Pt and a molecular weight of 300.05. Cisplatin, USP is a heavy metal complex containing a central atom of platinum surrounded by two chloride atoms and two ammonia molecules in the cis position. Web'lh hpsirkohqh 'rvlhuxqj yrq 'rfhwd[ho ehwuljw pj p dov vw qgljh ,qixvlrq jhirojw yrq &lvsodwlq pj p dov elv vw qgljh ,qixvlrq ehlgh qxu dq 7dj jhirojw yrq )oxrurxudflo pj p sur 7dj dov nrqwlqxlhuolfkh 6wxqghq ,qixvlrq ehu 7djh ehjlqqhqg dp (qgh ghu &lvsodwlq ,qixvlrq 'lh %hkdqgoxqj zlug dooh :rfkhq zlhghukrow ) u glh 9hudeuhlfkxqj yrq

WebApr 13, 2015 · FB Wortlaut der für die Fachinformation vorgesehenen Angaben. Fachinformation. FC 1. BEZEICHNUNG DES ARZNEIMITTELS. Cisplatin Accord 1 mg/ml Konzentrat zur Herstellung einer Infusionslösung. FD 2. QUALITATIVE UND QUANTITATIVE ZUSAMMENSETZUNG. 1 ml des Konzentrats zur Herstellung einer … WebFachinformation Cisplatin-Lösung Ribosepharm 1 Oktober 2009. 4.3 Gegenanzeigen – Überempfindlichkeit gegen Cisplatin, an-dere Platinverbindungen oder einen der sonstigen Bestandteile. – Cisplatin-Lösung ist bei schweren Nie …

WebPemetrexed Accord in combination with cisplatin The recommended dose of Pemetrexed Accord is 500 mg/m2 of body surface area (BSA) administered as an intravenous infusion over 10 minutes on the first day of each 21-day cycle. The recommended dose of cisplatin is 75 mg/m2 BSA infused over two hours approximately 30 minutes after completion

WebCisplatin United States Pharmacopeia (USP) Reference Standard Synonym (s): cis-Diammineplatinum (II) dichloride, cis-Dichlorodiammine platinum (II), cis-Platinum (II) diammine dichloride, Cisplatin Linear Formula: Pt (NH3)2Cl2 CAS Number: 15663-27-1 Molecular Weight: 300.05 MDL number: MFCD00011623 PubChem Substance ID: … maniscalco scheduleWebCisplatin Accord injection is a clear, colourless to pale yellow sterile solution of cisplatin 1 mg/mL and sodium chloride 9 mg/mL in water for injections. 4 CLINICAL PARTICULARS 4.1 T HERAPEUTIC INDICATIONS Cisplatin Accord is indicated for the palliative treatment of: • Metastatic non-seminomatous germ cell carcinoma; critical application rate foamWeb1. Mitä Cisplatin Accord 1 mg/ml on ja mihin sitä käytetään 2. Mitä sinun on tiedettävä, ennen kuin käytät Cisplatin Accord 1 mg/ml -valmistetta 3. Miten Cisplatin Accord 1 mg/ml -valmistetta käytetään 4. Mahdolliset haittavaikutukset 5. Cisplatin Accord 1 mg/ml -valmisteen säilyttäminen 6. Pakkauksen sisältö ja muuta tietoa 1. critical appraisal betekenisWebCisplatina Accord 1 mg / ml x 1 flacon x 50 ml concentrat pentru solutie perfuzabila - Catena. Cisplatina este un medicament care apartine unui grup de medicamente cunoscute sub numele de citostatice, utilizate in tratamentul cancerului. Cisplatina poate fi administrata singura sau in asociere cu alte citostatice. Aceasta poate distruge ... critical aortic stenosis valve areaWebFACHINFORMATION Februar 2024 Seite 2 von 7 Carboplatin 10 mg/ml Konzentrat zur Herstellung einer Infusionslösung FI-2169469_V.03 die Carboplatin-Therapie so lange aufzuschieben, bis eine Erholung des Knochenmarks erkennbar ist. Diese Erholung dauert gewöhnlich 5 bis 6 Wochen. Es können Transfusionen erforderlich sein und für die nachfol- maniscalco simpson desert glassWebCisplatin Accord® 10 mg/10 ml. Dosierung: 10 mg/10 ml. Darreichungsform: Durchstechflasche. Packungsgrösse: 1. Galenische Form: Konzentrat zur Herstellung einer Infusionslösung i.v. critical appraisal checklist cohortWebCisplatin forms part of a group of medicines called cytostatics, which are used in the treatment of cancer. Cisplatin can be used alone but more commonly Cisplatin is used in combination with other cytostatics. What is it used for? Cisplatin can destroy cells in your body that may cause certain types of maniscalco sobc311